Abstract:Recent human studies have suggested that aging interventions can reduce aging biomarkers related to morbidity and mortality risk. Such biomarkers may potentially serve as early, rapid indicators of effects on healthspan. An increasing number of studies are measuring intervention effects on epigenetic clocks, commonly used aging biomarkers based on DNA methylation profiles. However, with dozens of clocks to choose from, different clocks may not agree on the effect of an intervention. Furthermore, changes in some clocks may simply be the result of technical noise causing a false positive result. To address these issues, we measured the variability between 6 popular epigenetic clocks across a range of longitudinal datasets containing either an aging intervention or an age-accelerating event. We further compared them to the same clocks re-trained to have high test-retest reliability. We find the newer generation of clocks, trained on mortality or rate-of-aging, capture aging events more reliably than those clocks trained on chronological age, as these show consistent effects (or lack thereof) across multiple clocks including high-reliability versions, and including after multiple testing correction. In contrast, clocks trained on chronological age frequently show sporadic changes that are not replicable when using high-reliability versions of those same clocks, or when using newer generations of clocks and these results do not survive multiple-testing correction. These are likely false positive results, and we note that some of these clock changes were previously published, suggesting the literature should be re-examined. This work lays the foundation for future clinical trials that aim to measure aging interventions with epigenetic clocks, by establishing when to attribute a given change in biological age to a bona fide change in the aging process.

Exploring the potential of epigenetic clocks in aging research

Epigenetic clock: A promising biomarker and practical tool in aging

Comparative analysis of epigenetic aging clocks from CpG characteristics to functional associations

An evaluation of aging measures: from biomarkers to clocks

Epigenetic aging: Biological age prediction and informing a mechanistic theory of aging

Underlying features of epigenetic aging clocks in vivo and in vitro

Decoding aging clocks: New insights from metabolomics

Quantification of Epigenetic Aging in Public Health

Epigenetic clocks in neurodegenerative diseases: a systematic review

When to Trust Epigenetic Clocks: Avoiding False Positives in Aging Interventions.

Cell-type specific epigenetic clocks to quantify biological age at cell-type resolution

A systematic review of phenotypic and epigenetic clocks used for aging and mortality quantification in humans

Emerging epigenetic insights into aging mechanisms and interventions

Epigenomic, Transcriptome And Image-Based Biomarkers Of Aging

A computational solution for bolstering reliability of epigenetic clocks: Implications for clinical trials and longitudinal tracking

Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing

Many chronological aging clocks can be found throughout the epigenome: Implications for quantifying biological aging

Tick tock, tick tock: Mouse culture and tissue aging captured by an epigenetic clock

DNA methylation-based biomarkers and the epigenetic clock theory of ageing

[A research of omics-based biological aging clocks and their applications]

DNA methylation aging clocks: challenges and recommendations